Early worsening of diabetic retinopathy in the diabetes control and complications trial

Archives of Ophthalmology

Volumn 116, Issue 7, 1998, Pages 874-886

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; INSULIN TREATMENT; LASER COAGULATION; PRIORITY JOURNAL; STEREOSCOPIC VISION; TREATMENT PLANNING;

EID: 0031729874     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.7.874     Document Type: Article

References (34)

1. Daneman D, Drash AL, Lobes LA, Becker DJ, Baker LM, Travis LB. Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome). Diabetes Care. 1981;4:360-365.
2. Pucklin JE, Tamborlane WV, Felig P, Genel M, Sherwin RS. Influence of long-term insulin infusion pump treatment of type 1 diabetes on diabetic retinopathy. Ophthalmology. 1982;89:735-747.
3. Lawson PM, Champion MC, Canny C, Kingsley R, White MC. Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy. Br J Ophthalmol. 1982;66:762-766.
4. van Ballegooie E, Hooymans JM, Timmerman Z, et al. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care. 1984;7:236-242.
5. Lawrence JR, Bedford GJ, Thomson R. Rapid development during puberty of proliferative retinopathy after strict control. Lancet. 1985;2:322.
6. Dandona P, Bolger JP, Boag F, Fonesca V, Abrams JD. Rapid development and progression of proliferative retinopathy after strict diabetic control. BMJ. 1985;290:895-896.
7. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Steno Study Group. Effect of one year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983;1:200-204.
8. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes. 1985;34:74-79.
9. The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med. 1984;311:365-372.
10. The Kroc Collaborative Study Group. Diabetic retinopathy after too years of intensified insulin treatment. JAMA. 1988;260:37-41.
11. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik KF, Aagenaes O, Aker Diabetes Group. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: the Oslo Study. BMJ. 1985;290:811-815.
12. Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L, Oslo Study Group. Effects of intensified treatment on various lesions of diabetic retinopathy. Am J Ophthalmol. 1985;100:644-653.
13. Brinchmann-Hansen O, Dahl-Jorgensen K, Hannsen KF, Sandvik L. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. Arch Ophthalmol. 1988;106:1242-1246.
14. Funatsu H, Yamashita H, Ohashi Y, Ishigaki T. Effect of rapid glycemic control on progression of diabetic retinopathy. Jpn J Ophthalmol. 1992;36:356-367.
15. Agardh C-D, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes metlitus patients after improved metabolic control. J Diabetes Complications. 1992;6:96-100.
16. Gudat U, Chantelau E. Rapid-progressive diabetische Retinopathie bei Stoffwechselnormalisierung: wer ist gefährdet? Z Kiln Med. 1992;47:108-113.
17. Roysarkar TK, Gupta A, Dash RJ, Dogra MR. Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus. Am J Ophthalmol. 1993;115:569-574.
18. Moskalets E, Galstyan G, Starostina E, Antisiferov M, Chantelau E. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabetes Complications. 1994;8:45-50.
19. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes. 1986;35:530-545.
20. The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): update. Diabetes Care. 1990;13:427-433.
21. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
22. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol. 1995;113:36-51.
23. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98:786-806.
24. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. New York, NY: Chapman & Hall; 1989:98-123.
25. Korn EL, Simon R. Explained residual variation, explained risk, and goodness of fit Am Statistician. 1991;45:201-206.
26. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987:48-53.
27. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons Inc; 1980:70-118.
28. Lachin JM. Some large sample distribution-free estimators and tests for multivariate partially incomplete observations from two populations. Stat Med. 1992;11:1151-1170.
29. lc) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44:968-983.
30. DCCT Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18:361-375.
31. Ernest JT, Goldstick TK, Engerman RL. Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs. Invest Ophthalmol Vis Sci. 1983;24:985-989.
32. Kohner EM, Sleightholm M, Fallon T. Why does retinopathy deteriorate when diabetic control is improved? Invest Ophthalmol Vis Sci. 1987;29(suppl):244.
33. Grunwald JE, Brucker AJ, Schwarte SS, et al. Diabetic glycemic control and retinal blood flow. Diabetes. 1990;39:602-607.
34. Grunwald JE, Riva CE, Petrig BL, et al. Strict control of glycaemia: effects on blood flow in the large retinal vessels and in the macular microcirculation, Br J Ophthalmol. 1995;79:735-741.